【発明の名称】レチノイン酸レセプターβ2、そのアンタゴニスト、および神経障害治療用の遺伝子治療ベクター

Title:

【発明の名称】レチノイン酸レセプターβ2、そのアンタゴニスト、および神経障害治療用の遺伝子治療ベクター

Document Type and Number:

Japanese Patent JP2003533184

Kind Code:

A

Abstract:

The present invention relates to the use of RAR beta 2 and/or an agonist thereof in the preparation of a medicament to cause neurite development.

More Like This:

JP3573743	Assay to evaluate inhibition of human cyclooxygenase-2 cDNA and cyclooxygenase-2
WO/1993/000909	METHOD AND ASSAY SYSTEM FOR NEUROTROPHIN ACTIVITY
JP2514167	POLYPEPTIDE AND POLYPEPTIDE COMPOSITION

Inventors:

Alan John, Kingsman
Malden, Maiden
Corcoran, Jonathan Patrick Thomas

Application Number:

JP2001573009A

Publication Date:

November 11, 2003

Filing Date:

March 30, 2001

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Oxford Biomedica (Yuke) Limited

International Classes:

C12N15/09; A61K31/00; A61K31/203; A61K31/381; A61K35/76; A61K38/17; A61K45/00; A61K48/00; A61P3/02; A61P25/00; A61P43/00; C07K14/705; C12N5/10; C12N15/12; C12N15/867; C12Q1/02; C12Q1/68; G01N33/68; G01N33/74; C12R1/93; (IPC1-7): C12N15/09; A61K35/76; A61K45/00; A61K48/00; A61P3/02; A61P25/00; A61P43/00; C12N5/10; C12Q1/02; C12Q1/68

Attorney, Agent or Firm:

Okuyama Shoichi (2 outside)

Previous Patent: 選択マーカー遺伝子

Next Patent: 可変的構成をもつ細胞及び組織培養ユニット